All In Biotech

Drug Trial Radar · NCT07838740

A Phase 1 Study of VK2735 in Obese Adults Without Comorbidities

A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VK2735 Administration in Adults Who Are Obese (BMI ≥ 30 kg/m2) Without Comorbidities

Last checked: Nov 19, 2026Latest source record: Sep 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 270 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

270

Planned (sponsor's estimate)

Start

Nov 18, 2025

Primary completion

May 2027

Study completion Jul 2027

Sponsor

Lead sponsor
Viking Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Sep 24, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this Phase 1, randomized, double-blind, placebo-controlled study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of VK2735 in adults who are obese (BMI ≥ 30 kg/m2) without comorbidities.

Conditions

  • Obese Adults

Interventions

  • VK2735 DrugDrug

    SC or oral once daily, once weekly, every other week, or monthly

  • PlaceboDrug

    SC or oral once daily or once weekly

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluate the Safety and Tolerability VK2735Time frame: 33 weeks

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Viking Clinical Site #001

    Lake Forest, California · Recruiting

  • Viking Clinical Site #002

    Miami, Florida · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.